Susquehanna International Group, LLP Cin Cor Pharma, Inc. Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Cin Cor Pharma, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 15,300 shares of CINC stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,300Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CINC
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About CinCor Pharma, Inc.
- Ticker CINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,764,300
- Description
- CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...